Literature DB >> 28446560

GOLD 2017 on the way to a phenotypic approach? Analysis from the Phenotypes of COPD in Central and Eastern Europe (POPE) Cohort.

Neven Tudoric1, Vladimir Koblizek2, Marc Miravitlles3, Arschang Valipour4, Branislava Milenkovic5, Adam Barczyk6, Attila Somfay7, Kirill Zykov8, Kosta Kostov9, Zuzana Zbozinkova10, Michal Svoboda10, Jurij Sorli11, Alvils Krams12, Ruzena Tkacova13.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28446560     DOI： 10.1183/13993003.02518-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  18 in total

1.  Phenotypes of COPD in an Austrian population : National data from the POPE study.

Authors:  Gabriele Reiger; Ralf Zwick; Bernd Lamprecht; Christian Kähler; Otto Chris Burghuber; Arschang Valipour
Journal:  Wien Klin Wochenschr       Date:  2018-05-24       Impact factor: 1.704

2.  Prognostic Accuracy of Three COPD Classification Systems in Relation to Long-Term Mortality of COPD Patients: A Prospective Multicenter Study.

Authors:  Marek Plutinsky; Kristian Brat; Michal Svoboda; Jaromir Zatloukal; Patrice Popelkova; Vladimir Koblizek
Journal:  Lung       Date:  2019-01-29       Impact factor: 2.584

3.  Classification and treatment of chronic obstructive pulmonary disease outpatients in China according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017: comparison with GOLD 2014.

Authors:  Yanan Cui; Zhongshang Dai; Lijuan Luo; Ping Chen; Yan Chen
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

4.  Changes in the Burden of Comorbidities in Patients with COPD and Asthma-COPD Overlap According to the GOLD 2017 Recommendations.

Authors:  András Bikov; Alpár Horváth; Gábor Tomisa; Liza Bártfai; Zoltán Bártfai
Journal:  Lung       Date:  2018-07-14       Impact factor: 2.584

5.  Therapeutic Success of Tiotropium/Olodaterol, Measured Using the Clinical COPD Questionnaire (CCQ), in Routine Clinical Practice: A Multinational Non-Interventional Study.

Authors:  Arschang Valipour; Sergey Avdeev; Adam Barczyk; Valentina Bayer; Zvi Fridlender; Mariela Georgieva; Ondřej Kudela; Alexey Medvedchikov; Ramona Miron; Maria Sanzharovskaya; Virginija Šileikienė; Jurij Šorli; Marc Spielmanns; Zsuzsanna Szalai
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-03-10

Review 6.  Inhaled therapies in patients with moderate COPD in clinical practice: current thinking.

Authors:  Amnon Ariel; Alan Altraja; Andrey Belevskiy; Piotr W Boros; Edvardas Danila; Matjaz Fležar; Vladimir Koblizek; Zvi G Fridlender; Kosta Kostov; Alvils Krams; Branislava Milenkovic; Attila Somfay; Ruzena Tkacova; Neven Tudoric; Ruxandra Ulmeanu; Arschang Valipour
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-12-21

7.  Respiratory parameters predict poor outcome in COPD patients, category GOLD 2017 B.

Authors:  Kristian Brat; Marek Plutinsky; Karel Hejduk; Michal Svoboda; Patrice Popelkova; Jaromir Zatloukal; Eva Volakova; Miroslava Fecaninova; Lucie Heribanova; Vladimir Koblizek
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-03-26

8.  Phenotype and management of chronic obstructive pulmonary disease patients in general population in China: a nationally cross-sectional study.

Authors:  Heling Bao; Guohua Jia; Shu Cong; Wanlu Sun; Jing Fan; Ning Wang; Yajing Feng; Baohua Wang; Jeffrey L Curtis; Linhong Wang; Liwen Fang; Yahong Chen
Journal:  NPJ Prim Care Respir Med       Date:  2021-06-01       Impact factor: 2.871

9.  Classification of COPD patients and compliance to recommended treatment in Greece according to GOLD 2017 report: the RELICO study.

Authors:  Nikolaos Tzanakis; Nikolaos Koulouris; Katerina Dimakou; Konstantinos Gourgoulianis; Epameinondas Kosmas; Georgia Chasapidou; Athanasios Konstantinidis; Christos Kyriakopoulos; Theodoros Kontakiotis; Aggeliki Rapti; Mina Gaga; Konstantinos Kalafatakis; Konstantinos Kostikas
Journal:  BMC Pulm Med       Date:  2021-07-09       Impact factor: 3.317

10.  Changes in definition lead to changes in the clinical characteristics across COPD categories according to GOLD 2017: a national cross-sectional survey in China.

Authors:  Lina Sun; Yahong Chen; Rui Wu; Ming Lu; Wanzhen Yao
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.